Chinese medical equipment manufacturer Envision Communications says it has developed a device to measure the heart rates of patients using wearable devices.
The device is based on the “heart rate monitor” that is already being used in hospitals.
Envision has developed the device called a “Heart Rate Stable Monitoring Device”, or HRTD.
The company says the device is “designed to be implanted in patients and used to monitor their heart rates” and it has received approval from the US Food and Drug Administration (FDA) for use.
In its press release, the company said it was “in the early stages of development”, but the device could be ready to be used within five years.
“We have a long history of building the world’s most advanced wearable health monitoring products,” Envision Chief Executive Officer Xu Xin said in a statement.
“Our HRTDs are the first of their kind to use an advanced technology to measure heart rate variability and can be worn under clothing.”
Xu said that by measuring the amount of oxygen in the body, the device can be used to assess the health of a patient.
“Heart rate variability is the most reliable way to assess a patient’s health and its a common measure used by physicians to make decisions about patients,” he said.
This allows patients to maintain the highest levels of physical activity, and to improve their physical health and quality of life.” “
With a HRT device, patients can have their heart rate monitored for up to 12 hours a day, 24 hours a week, in any setting.
This allows patients to maintain the highest levels of physical activity, and to improve their physical health and quality of life.”
Envision is part of a wave of Chinese medical technology companies making the push for innovation in the field of wearable health.
In the last few years, companies like Beijing Medical Devices, Nanfang Medical, and Tianjin Medical Technology have become major players in the health wearable space.
The market for wearable health tracking devices is expected to grow exponentially in the next few years.
A 2015 survey by healthcare technology research company The Healthcare Intelligence Group found that more than 90% of healthcare organisations are using wearable technology.
The HRT devices are becoming more popular in China, but the devices have yet to gain widespread acceptance.
There are currently more than 1,000 patents pending in China on wearable devices for monitoring health and wellbeing.
The US Food & Drug Administration approved Envision’s HRTDA for use in the United States in January 2016.
The FDA approved the device as “a therapeutic communication technique” in the same year.
But it is unclear whether the device will ever reach the market in the US.
“As a non-profit company, Envision remains committed to providing innovative products and services to our community of healthcare professionals, and we remain hopeful that the FDA will allow Envision to participate in the U.S. market,” Xu said.
China’s healthcare system has been plagued by a shortage of health professionals, leading to a rise in infections.
China has more than three million hospital beds, and in 2014, it had the highest number of hospitalisations in the world.
The country is also the world leader in a number of medical technologies.
Envoy has been working on developing a wearable device since 2014.
“This device will allow doctors to monitor patients’ health and their quality of lives, and it will help to prevent chronic disease, as well as prevent hospitalisations,” Xu added.
The new device, which is in clinical trials in China and will be available to patients in 2020, is the latest in a wave by Chinese healthcare companies that aim to gain mainstream acceptance in the West.
In 2018, a group of Chinese companies led by healthcare software company Tianjin Technology signed a partnership with American company Bioconductor, and later signed a deal with Microsoft.
That deal, with Microsoft, will see Tianjin Technologies produce and distribute a version of its HealthIQ device.
“The HRT technology and its platform will help doctors to track patients’ daily activities and their health in real-time,” Wang Yu, an expert in healthcare technology at Harvard University, told Al Jazeera.
“A large part of the problems in health care are related to the lack of health information.
That will help physicians to focus on their patients’ quality of their health.”
A spokesperson for the FDA told Al Sharq Alq on Friday that the agency had not received any requests from Envision or Tianjin for the use of their devices.
“Currently, the FDA does not have an order to allow the use by health professionals for this purpose,” the spokesperson said.